SlideShare a Scribd company logo
Is shigellosis among MSM a widespread
problem? An analysis of EU/EEA
surveillance data 2009-2014
Gianfranco Spiteri, T. Westrell, O. Mårdh
European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Background
• Shigellosis outbreaks associated with sexual transmission among men who have sex with men (MSM) have been
reported in recent years from the United Kingdom, Germany and Spain, with severe infections among HIV-positive
MSM. A recent report from England identified high male-to-female ratios of reported domestic shigellosis cases as
an indicator of transmission among MSM.
• European Shigella surveillance data include limited information on sexual transmission. We therefore explored
surveillance data reported to ECDC to assess whether men are over-represented among domestic shigellosis cases,
suggesting possible sexual transmission among MSM and the need for specific public health prevention measures.
Results
• During 2009 to 2014, travel-related shigellosis cases decreased overall (from 1378 to 1013) and among both
genders as reported from 23 countries (Figure 1).
• In contrast, domestically acquired cases increased from 691 to 1071 and accounted for 51% of reported shigellosis
cases in 2014 compared to 33% in 2009; among men, domestically acquired cases doubled from 364 to 735 and
accounted for 63% of cases in 2014, compared to 39% in 2009.
• Male-to-female ratios increased among both travel-related (0.7 to 0.8) and domestic cases (1.1 to 2.3).
• Among domestic cases (2012-2014), the male-to-female ratio was 2.0 or above in the EU/EEA overall and in Austria,
France, Germany, Ireland, the Netherlands, Poland and Spain (Figure 2).
• Male-to-female ratios were 2.0 or above among domestic cases for: S. flexneri serotype 3a (2009-2014), 2a (2010-
2014), 1b (2010, 2012), 6 (2013) and other serotypes (2009-2014); S. sonnei (2011); and unknown Shigella species
(2014).
Conclusions
• The excess of males among domestically acquired cases of shigellosis in several countries suggests ongoing sexual
transmission particularly for S. flexneri serotype 3a among MSM in Europe.
• European countries with high male-to-female ratios among domestic shigellosis cases should consider more detailed
investigation of domestic male shigellosis cases including collecting data on sexual transmission.
• Reporting of sexual transmission of shigellosis cases at national and European level could facilitate interpretation of
trends and allow public health interventions, including raising awareness among clinicians and MSM, particularly
HIV-positive individuals at risk of severe outcomes.
Figure 1: Trends in shigellosis cases in the EU/EEA by place of
infection and gender, 2009-2014
Figure 2: Shigellosis male-to-female ratios in EU/EEA Member
States, 2012-2014
www.ecdc.europa.eu
Methods
• We analysed EU/EEA shigellosis surveillance data submitted to The European Surveillance System between 2009 and
2014.
• We assessed trends by gender and origin of infection among cases aged 16-65 years to determine the proportion of
males among domestically acquired and travel-associated infections.
• Male-to-female ratios were calculated for domestically acquired cases by country (aggregated for 2012-2014) and by
Shigella species (and serotype for S. flexneri) over time.

More Related Content

What's hot

Surveillance data on hepatitis B and C in EU/EEA 2014
Surveillance data on hepatitis B and C in EU/EEA 2014Surveillance data on hepatitis B and C in EU/EEA 2014
Surveillance data on hepatitis B and C in EU/EEA 2014
European Centre for Disease Prevention and Control
 
Supporting the global vision of hepatitis B and C elimination - poster for IL...
Supporting the global vision of hepatitis B and C elimination - poster for IL...Supporting the global vision of hepatitis B and C elimination - poster for IL...
Supporting the global vision of hepatitis B and C elimination - poster for IL...
European Centre for Disease Prevention and Control
 
Surveillance of hepatitis B and C in the EU/EEA: 2013 data
Surveillance of hepatitis B and C in the EU/EEA: 2013 dataSurveillance of hepatitis B and C in the EU/EEA: 2013 data
Surveillance of hepatitis B and C in the EU/EEA: 2013 data
European Centre for Disease Prevention and Control
 
Hepatitis B and C surveillance in the EU/EEA 2015
Hepatitis B and C surveillance in the EU/EEA 2015Hepatitis B and C surveillance in the EU/EEA 2015
Hepatitis B and C surveillance in the EU/EEA 2015
European Centre for Disease Prevention and Control
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
European Centre for Disease Prevention and Control
 
HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe
European Centre for Disease Prevention and Control
 
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
European Centre for Disease Prevention and Control
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
European Centre for Disease Prevention and Control
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
European Centre for Disease Prevention and Control
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
European Centre for Disease Prevention and Control
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
European Centre for Disease Prevention and Control
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
European Centre for Disease Prevention and Control
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
European Centre for Disease Prevention and Control
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
European Centre for Disease Prevention and Control
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
European Centre for Disease Prevention and Control
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
European Centre for Disease Prevention and Control
 
graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016
European Centre for Disease Prevention and Control
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
European Centre for Disease Prevention and Control
 

What's hot (20)

Surveillance data on hepatitis B and C in EU/EEA 2014
Surveillance data on hepatitis B and C in EU/EEA 2014Surveillance data on hepatitis B and C in EU/EEA 2014
Surveillance data on hepatitis B and C in EU/EEA 2014
 
Supporting the global vision of hepatitis B and C elimination - poster for IL...
Supporting the global vision of hepatitis B and C elimination - poster for IL...Supporting the global vision of hepatitis B and C elimination - poster for IL...
Supporting the global vision of hepatitis B and C elimination - poster for IL...
 
Surveillance of hepatitis B and C in the EU/EEA: 2013 data
Surveillance of hepatitis B and C in the EU/EEA: 2013 dataSurveillance of hepatitis B and C in the EU/EEA: 2013 data
Surveillance of hepatitis B and C in the EU/EEA: 2013 data
 
Hepatitis B and C surveillance in the EU/EEA 2015
Hepatitis B and C surveillance in the EU/EEA 2015Hepatitis B and C surveillance in the EU/EEA 2015
Hepatitis B and C surveillance in the EU/EEA 2015
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
 
HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe
 
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
 
Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
 
graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
 

Viewers also liked

Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
Enterobacteriaceae
Aman Ullah
 
Shigellosis
ShigellosisShigellosis
Shigellosis
Amal Osman
 
Shigella
ShigellaShigella
Shigella
Scorpion_55
 
Shigelosis
ShigelosisShigelosis
E. coli, Klebsiella & proteus
E. coli, Klebsiella & proteusE. coli, Klebsiella & proteus
E. coli, Klebsiella & proteusbnsree
 
Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
EnterobacteriaceaeGopi sankar
 
Bacillary dysentery (shigellosis)
Bacillary dysentery (shigellosis)Bacillary dysentery (shigellosis)
Bacillary dysentery (shigellosis)Hallmark Mojica
 
Tsi test
Tsi testTsi test
Tsi test
Mehraj Alam
 
Bacillary Dysentery
Bacillary DysenteryBacillary Dysentery
Bacillary Dysentery
Lean
 
E coli, klebsiella, enterobacter lecture notes
E coli, klebsiella, enterobacter lecture notesE coli, klebsiella, enterobacter lecture notes
E coli, klebsiella, enterobacter lecture notesBruno Mmassy
 
Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
Enterobacteriaceae
babasahebkumbhar
 
Pseudomonas
PseudomonasPseudomonas
Pseudomonas
Sandeep Kaur Chahal
 

Viewers also liked (20)

Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
Enterobacteriaceae
 
Shigellosis
ShigellosisShigellosis
Shigellosis
 
Shigellosis
ShigellosisShigellosis
Shigellosis
 
Shigella
ShigellaShigella
Shigella
 
Shigelosis
ShigelosisShigelosis
Shigelosis
 
E. coli, Klebsiella & proteus
E. coli, Klebsiella & proteusE. coli, Klebsiella & proteus
E. coli, Klebsiella & proteus
 
Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
Enterobacteriaceae
 
Bacillary dysentery (shigellosis)
Bacillary dysentery (shigellosis)Bacillary dysentery (shigellosis)
Bacillary dysentery (shigellosis)
 
Shigella
ShigellaShigella
Shigella
 
Tsi test
Tsi testTsi test
Tsi test
 
Bacillary Dysentery
Bacillary DysenteryBacillary Dysentery
Bacillary Dysentery
 
Klebsiella
KlebsiellaKlebsiella
Klebsiella
 
Shigellosis
ShigellosisShigellosis
Shigellosis
 
E coli, klebsiella, enterobacter lecture notes
E coli, klebsiella, enterobacter lecture notesE coli, klebsiella, enterobacter lecture notes
E coli, klebsiella, enterobacter lecture notes
 
Klebsiella
KlebsiellaKlebsiella
Klebsiella
 
Enterobacteriaceae
EnterobacteriaceaeEnterobacteriaceae
Enterobacteriaceae
 
Shigella
ShigellaShigella
Shigella
 
Pseudomonas
PseudomonasPseudomonas
Pseudomonas
 
Klebsiella pneumoniae
Klebsiella pneumoniaeKlebsiella pneumoniae
Klebsiella pneumoniae
 
Shigella sp
Shigella spShigella sp
Shigella sp
 

Similar to Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveillance data 2009-2014, ESCAIDE 2016

HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
European Centre for Disease Prevention and Control
 
Hiv aids-surveillance-report-2012
Hiv aids-surveillance-report-2012Hiv aids-surveillance-report-2012
Hiv aids-surveillance-report-2012Gaby Frankfurt
 
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
European Centre for Disease Prevention and Control
 
Clinical Epidemiological Study of Secondary Syphilis - Current Scenario
Clinical Epidemiological Study of Secondary Syphilis - Current ScenarioClinical Epidemiological Study of Secondary Syphilis - Current Scenario
Clinical Epidemiological Study of Secondary Syphilis - Current Scenario
iosrjce
 
2009 aids epidemic update
2009 aids epidemic update2009 aids epidemic update
2009 aids epidemic update
Pim Piepers
 
Ebola_2014_outbreak
Ebola_2014_outbreakEbola_2014_outbreak
Ebola_2014_outbreakDagmara Grad
 
Chancroid - a rare disease in Europe, IUSTI Europe 2016
Chancroid - a rare disease in Europe, IUSTI Europe 2016Chancroid - a rare disease in Europe, IUSTI Europe 2016
Chancroid - a rare disease in Europe, IUSTI Europe 2016
European Centre for Disease Prevention and Control
 
Prevalence of hiv infection in pulmonary tuberculosis suspects;
Prevalence of hiv infection in pulmonary tuberculosis suspects;Prevalence of hiv infection in pulmonary tuberculosis suspects;
Prevalence of hiv infection in pulmonary tuberculosis suspects;
Alexander Decker
 
Social diseases germany
Social diseases germanySocial diseases germany
Social diseases germany
Mahesh Kumar
 
Latest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDCLatest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDC
European Centre for Disease Prevention and Control
 
A Case Study Secondary Syphilis With HIV
A Case Study  Secondary Syphilis With HIVA Case Study  Secondary Syphilis With HIV
A Case Study Secondary Syphilis With HIV
Fiona Phillips
 
Thisthesisis basedonthefollowing papers,whichwill bereferredto by theirroman ...
Thisthesisis basedonthefollowing papers,whichwill bereferredto by theirroman ...Thisthesisis basedonthefollowing papers,whichwill bereferredto by theirroman ...
Thisthesisis basedonthefollowing papers,whichwill bereferredto by theirroman ...
Luanvanyhoc.com-Zalo 0927.007.596
 
Vino final powerpoint
Vino final powerpointVino final powerpoint
Vino final powerpointViroNovative
 
Hepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 dataHepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 data
European Centre for Disease Prevention and Control
 
Aids awareness
Aids awarenessAids awareness
Aids awareness마 이환
 
Hiv in the_uk_2015_report
Hiv in the_uk_2015_reportHiv in the_uk_2015_report
Hiv in the_uk_2015_report
Polleetickle
 
The epidemiology of tuberculosis in Kenya, a high TB/HIV burden country (2000...
The epidemiology of tuberculosis in Kenya, a high TB/HIV burden country (2000...The epidemiology of tuberculosis in Kenya, a high TB/HIV burden country (2000...
The epidemiology of tuberculosis in Kenya, a high TB/HIV burden country (2000...
Premier Publishers
 
Per contact probability of infection by Highly Pathogenic Avian Influenza
Per contact probability of infection by Highly Pathogenic Avian InfluenzaPer contact probability of infection by Highly Pathogenic Avian Influenza
Per contact probability of infection by Highly Pathogenic Avian Influenza
Harm Kiezebrink
 
Dengue in Sri Lanka - Rivin
Dengue in Sri Lanka - RivinDengue in Sri Lanka - Rivin
Dengue in Sri Lanka - Rivin
Rivindu Wickramanayake
 

Similar to Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveillance data 2009-2014, ESCAIDE 2016 (20)

HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
HIV infection among persons aged 50 years and over in the EU, 2004–2013: miss...
 
Hiv aids-surveillance-report-2012
Hiv aids-surveillance-report-2012Hiv aids-surveillance-report-2012
Hiv aids-surveillance-report-2012
 
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
 
Clinical Epidemiological Study of Secondary Syphilis - Current Scenario
Clinical Epidemiological Study of Secondary Syphilis - Current ScenarioClinical Epidemiological Study of Secondary Syphilis - Current Scenario
Clinical Epidemiological Study of Secondary Syphilis - Current Scenario
 
2009 aids epidemic update
2009 aids epidemic update2009 aids epidemic update
2009 aids epidemic update
 
Ebola_2014_outbreak
Ebola_2014_outbreakEbola_2014_outbreak
Ebola_2014_outbreak
 
Chancroid - a rare disease in Europe, IUSTI Europe 2016
Chancroid - a rare disease in Europe, IUSTI Europe 2016Chancroid - a rare disease in Europe, IUSTI Europe 2016
Chancroid - a rare disease in Europe, IUSTI Europe 2016
 
Prevalence of hiv infection in pulmonary tuberculosis suspects;
Prevalence of hiv infection in pulmonary tuberculosis suspects;Prevalence of hiv infection in pulmonary tuberculosis suspects;
Prevalence of hiv infection in pulmonary tuberculosis suspects;
 
Social diseases germany
Social diseases germanySocial diseases germany
Social diseases germany
 
Latest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDCLatest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDC
 
A Case Study Secondary Syphilis With HIV
A Case Study  Secondary Syphilis With HIVA Case Study  Secondary Syphilis With HIV
A Case Study Secondary Syphilis With HIV
 
Thisthesisis basedonthefollowing papers,whichwill bereferredto by theirroman ...
Thisthesisis basedonthefollowing papers,whichwill bereferredto by theirroman ...Thisthesisis basedonthefollowing papers,whichwill bereferredto by theirroman ...
Thisthesisis basedonthefollowing papers,whichwill bereferredto by theirroman ...
 
Vino final powerpoint
Vino final powerpointVino final powerpoint
Vino final powerpoint
 
EpiBrief_2_2014
EpiBrief_2_2014EpiBrief_2_2014
EpiBrief_2_2014
 
Hepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 dataHepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 data
 
Aids awareness
Aids awarenessAids awareness
Aids awareness
 
Hiv in the_uk_2015_report
Hiv in the_uk_2015_reportHiv in the_uk_2015_report
Hiv in the_uk_2015_report
 
The epidemiology of tuberculosis in Kenya, a high TB/HIV burden country (2000...
The epidemiology of tuberculosis in Kenya, a high TB/HIV burden country (2000...The epidemiology of tuberculosis in Kenya, a high TB/HIV burden country (2000...
The epidemiology of tuberculosis in Kenya, a high TB/HIV burden country (2000...
 
Per contact probability of infection by Highly Pathogenic Avian Influenza
Per contact probability of infection by Highly Pathogenic Avian InfluenzaPer contact probability of infection by Highly Pathogenic Avian Influenza
Per contact probability of infection by Highly Pathogenic Avian Influenza
 
Dengue in Sri Lanka - Rivin
Dengue in Sri Lanka - RivinDengue in Sri Lanka - Rivin
Dengue in Sri Lanka - Rivin
 

More from European Centre for Disease Prevention and Control

Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
European Centre for Disease Prevention and Control
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
European Centre for Disease Prevention and Control
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
European Centre for Disease Prevention and Control
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
European Centre for Disease Prevention and Control
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
European Centre for Disease Prevention and Control
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
European Centre for Disease Prevention and Control
 
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
European Centre for Disease Prevention and Control
 
Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...
European Centre for Disease Prevention and Control
 
Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...
European Centre for Disease Prevention and Control
 
Addressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in careAddressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in care
European Centre for Disease Prevention and Control
 
Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018
European Centre for Disease Prevention and Control
 
Monitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countriesMonitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countries
European Centre for Disease Prevention and Control
 
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
European Centre for Disease Prevention and Control
 

More from European Centre for Disease Prevention and Control (15)

Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Respondent Driven Sampling
 
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
 
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
 
Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...
 
Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...
 
Addressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in careAddressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in care
 
Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018
 
Monitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countriesMonitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countries
 
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
Tuberculosis Action Plan for the WHO European Region 2016-2020 EU/EEA - 2016 ...
 

Recently uploaded

Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 

Recently uploaded (20)

Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 

Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveillance data 2009-2014, ESCAIDE 2016

  • 1. Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveillance data 2009-2014 Gianfranco Spiteri, T. Westrell, O. Mårdh European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden Background • Shigellosis outbreaks associated with sexual transmission among men who have sex with men (MSM) have been reported in recent years from the United Kingdom, Germany and Spain, with severe infections among HIV-positive MSM. A recent report from England identified high male-to-female ratios of reported domestic shigellosis cases as an indicator of transmission among MSM. • European Shigella surveillance data include limited information on sexual transmission. We therefore explored surveillance data reported to ECDC to assess whether men are over-represented among domestic shigellosis cases, suggesting possible sexual transmission among MSM and the need for specific public health prevention measures. Results • During 2009 to 2014, travel-related shigellosis cases decreased overall (from 1378 to 1013) and among both genders as reported from 23 countries (Figure 1). • In contrast, domestically acquired cases increased from 691 to 1071 and accounted for 51% of reported shigellosis cases in 2014 compared to 33% in 2009; among men, domestically acquired cases doubled from 364 to 735 and accounted for 63% of cases in 2014, compared to 39% in 2009. • Male-to-female ratios increased among both travel-related (0.7 to 0.8) and domestic cases (1.1 to 2.3). • Among domestic cases (2012-2014), the male-to-female ratio was 2.0 or above in the EU/EEA overall and in Austria, France, Germany, Ireland, the Netherlands, Poland and Spain (Figure 2). • Male-to-female ratios were 2.0 or above among domestic cases for: S. flexneri serotype 3a (2009-2014), 2a (2010- 2014), 1b (2010, 2012), 6 (2013) and other serotypes (2009-2014); S. sonnei (2011); and unknown Shigella species (2014). Conclusions • The excess of males among domestically acquired cases of shigellosis in several countries suggests ongoing sexual transmission particularly for S. flexneri serotype 3a among MSM in Europe. • European countries with high male-to-female ratios among domestic shigellosis cases should consider more detailed investigation of domestic male shigellosis cases including collecting data on sexual transmission. • Reporting of sexual transmission of shigellosis cases at national and European level could facilitate interpretation of trends and allow public health interventions, including raising awareness among clinicians and MSM, particularly HIV-positive individuals at risk of severe outcomes. Figure 1: Trends in shigellosis cases in the EU/EEA by place of infection and gender, 2009-2014 Figure 2: Shigellosis male-to-female ratios in EU/EEA Member States, 2012-2014 www.ecdc.europa.eu Methods • We analysed EU/EEA shigellosis surveillance data submitted to The European Surveillance System between 2009 and 2014. • We assessed trends by gender and origin of infection among cases aged 16-65 years to determine the proportion of males among domestically acquired and travel-associated infections. • Male-to-female ratios were calculated for domestically acquired cases by country (aggregated for 2012-2014) and by Shigella species (and serotype for S. flexneri) over time.